PATENT CLAIM ANALYSIS

Application Number: 15940152
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "457000"]

Abstract:
A compound can be a fluorescent taxane derivative having a structure of Formula 1, salt, stereoisomer, tautomer, polymorph, or solvate thereof. Formula 1 can be defined as: L, L-NH, or L-NH—C═O is a linker; and R is a substituent, where —OH, —O − , —NH 2 , and NH—CH 3  are examples. Examples of linkers can include glycine, beta-alanine, gamma-aminobutyric acid (GABA). Pharmaceutical compositions can include the compound and a pharmaceutically acceptable carrier, and may be configured for intravenous injection. The fluorescent taxane derivative can be used to treat cancer and non-cancer diseases. The fluorescent taxane derivative can be used to monitor cellular efflux and determine whether a cell will efflux paclitaxel.

Claim (Index 12):
The compound of  claim 2 , wherein the taxane is selected from:

Metadata:
- Claim Count in Document: 33.0
- Percentile: 90.0
- Lexical Diversity: 1.675
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13202426', '14873776', '14971153', '13558886', '14953860']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7304198813457615
- 35 USC 102 Novelty (BERT): 0.5298659442053977
- Combined Prediction Score: 0.7103644876317251
- Mean Citation Score: 216.597674
- Max Citation Score: 224.47897000000003
- Similarity Product: 107.8939187060708

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test